buthionine sulfoximine and glutathione synthesis Lowering level by enhances in vivo photodynamic therapy using chlorin e6-loaded nanoparticles Cited in 26 publications Sigma-Aldrich ʟ-Buthionine-sulfoximine, CAS 83730-53-4, ≥97%
Sigma Aldrich Buthionine sulfoximine, CAS 83730 53 4, 97% (TLC) 500 mg buthionine sulfoximine glutathione synthesis inhibitor Markedly Decreased Expression of S Transferase Gene in Human Cancer Cell Lines Resistant to Sulfoximine, an of Cellular Glutathione () Preclinical evaluation of azathioprine plus Sigma Aldrich Buthionine sulfoximine, CAS 5072 26 4, 99.0% (TLC) 250 mg Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




